Interleukin-6, an inflammatory cytokine, is characterized by pleiotrop
y and redundancy of action. Apart from its hematologic, immune, and he
patic effects, it has many endocrine and metabolic actions. Specifical
ly, it is a potent stimulator of the hypothalamic-pituitary-adrenal ax
is and is under the tonic negative control of glucocorticoids. It acut
ely stimulates the secretion of growth hormone, inhibits thyroid-stimu
lating hormone secretion, and decreases serum lipid concentrations. Fu
rthermore, it is secreted during stress and is positively controlled b
y catecholamines. Administration of interleukin-6 results in fever, an
orexia, and fatigue. Elevated levels of circulating interleukin-6 have
been seen in the steroid withdrawal syndrome and in the severe inflam
matory, infectious, and traumatic states potentially associated with t
he inappropriate secretion of vasopressin. Levels of circulating inter
leukin-6 are also elevated in several inflammatory diseases, such as r
heumatoid arthritis. Interleukin-6 is negatively controlled by estroge
ns and androgens, and it plays a central role in the pathogenesis of t
he osteoporosis seen in conditions characterized by increased bone res
orption, such as sex-steroid deficiency and hyperparathyroidism. Overp
roduction of interleukin-6 may contribute to illness during aging and
chronic stress. Finally, administration of recombinant human interleuk
in-6 may serve as a stimulation test for the integrity of the hypothal
amic-pituitary-adrenal axis.